• Peregrine Pharmaceuticals, Inc. (PPHM) Presents Promising Phase II Survival Data in Recurrent GBM With Single Treatment of Cotara More... 

• Ariad Pharmaceuticals, Inc. (ARIA) Says Ponatinib Well Tolerated In Small Group Of AML Patients More... 

• Cytokinetics, Inc. (CYTK) Announces Successful Completion of Phase IIA More... 

• MolMed S.p.A. Release: Results of three Phase II Trials in Lung Cancer Indications Confirm Safety and Antitumour Activity of NGR-hTNF More...

• New Therapy for Blood Cancers Using Drug Combo, Report in Clinical Cancer Research More... 

• Baked Goods May Improve Milk Allergy Symptoms: Mount Sinai Medical Center More... 

• Estrogen Buildup Spikes Blood Pressure, American Journal of Physiology Study More... 

• Iroko Pharmaceuticals: Early Results of Development Program in Nano-Formulated NSAIDs Show Potential for Faster Pain Relief at Lower Doses More... 

• LifeVantage Corporation (LFVN)'s Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article More...

• Ex-Lee Research Institute Employees Charged with Falsifying Clinical Study Data; Pharma Giants Like Schering-Plough Corporation (SGP), Merck & Co., Inc. (MRK) Were Clients More... 

• Endo Pharmaceuticals (ENDP) Sued by Sales Representatives More... 

• Watson Pharmaceuticals, Inc. (WPI): Pfizer Inc. (PFE) Seeks To Block Generic Viagra More...

 

• Histogen, Inc. Interprets Court Ruling as Victory in Patent Infringement Suit More... 

• IMPAX Laboratories, Inc. (IPXL) Confirms Patent Suit Relating to Generic Detrol(R) Immediate-Release 1 mg and 2 mg Tablets More...

• Amgen (AMGN) to Cut 150 Jobs in Boulder, Longmont More...



• So Close They Can Taste It; NanoBio Corporation, Investors Eye Potential IPO More...

• New Company, Airway Therapeutics LLC Formed More...

• Ligand Pharmaceuticals Inc. (LGND) and The Medicines Company (MDCO) Agree to Worldwide License for Proprietary Captisol(R); Ligand Eligible to Receive up to $22 Million More... 

• Pfizer Inc. (PFE) Plans China Low-Cost Generics Drug Venture With Hisun More... 

• Laureate Biopharmaceutical Services, Inc. Release: Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1 More... 

• INC Research, Inc. Hits Major Milestone With Trusted Process QuickStart Phase More... 

• Clovis Oncology Receives License for Worldwide Development and Commercialization Rights to Pfizer Inc. (PFE)'s Oral and IV PARP Inhibitor PF-01367338 More...

• Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO More... 

• Addex Pharmaceuticals (ADXN.SW) CEO Steps Down More... 

• DURECT Corporation (DRRX) Announces Resignation of Chief Medical Officer More... 

• CNS Response Elects David B. Jones of SAIL Venture Partners as New Board Chair More... 

• American Medical Association Names Dr. James Madara New EVP/CEO More...

• Chinese Biotech Company Tasly Pharmaceutical to Invest $40 Million in MontCo More...